NU-sjukvården är en sjukhusförvaltning inom Västra Götalandsregionen. N står för Norra Älvsborgs länssjukhus, medan U står för Uddevalla sjukhus. NU-sjukvården är en av fyra sjukhusgrupper i Västra Götalandsregionen, som är landstinget för Västra Götalands län.

During the past decade, Norra Älvsborgs Länssjukhus conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Norra Älvsborgs Länssjukhus" #1 sponsor was "Dilafor AB" with 2 trials, followed by "Annika Bergquist" with 1 trials sponsored, "Fresenius Medical Care Deutschland GmbH" with 1 trials sponsored, "Karolinska Institutet" with 1 trials sponsored and "Region Örebro County" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norra Älvsborgs Länssjukhus" #1 collaborator was "Region Stockholm" with 1 trials as a collaborator, "Swedish Heart Lung Foundation" with 1 trials as a collaborator, "The Swedish Research Council" with 1 trials as a collaborator and "Uppsala University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Norra Älvsborgs Länssjukhus" are "Acute Myocardial Infarction" (1 trials), "Cardiovascular Diseases" (1 trials), "Chronic Renal Failure" (1 trials), "GastroIntestinal Bleeding" (1 trials) and "Helicobacter Pylori Infection" (1 trials). Many other conditions were trialed in "Norra Älvsborgs Länssjukhus" in a lesser frequency.

Most popular intervention types in "Norra Älvsborgs Länssjukhus" are "Drug" (3 trials), "Diagnostic Test" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "DF 01" (1 trials), "DF01" (1 trials), "Oxytocin" (1 trials) and "Placebo oral tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Norra Älvsborgs Länssjukhus" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Norra Älvsborgs Länssjukhus". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Norra Älvsborgs Länssjukhus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Norra Älvsborgs Länssjukhus, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".